SG Americas Securities
ELOX

SG Americas Securities’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

SG Americas Securities’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-363
Closed -$44K – 3691
2020
Q2 		$44K Buy
+363
New +$41.1K ﹤0.01% 3553

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SG Americas Securities's ELOX Position: Q3 2020 in Review

SG Americas Securities sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2020, closing a stake of 363 shares — an estimated $44K sold.

SG Americas Securities first reported a position in ELOX in Q2 2020 and held it in 1 quarter. The position peaked at $44K in Q2 2020. 37 funds tracked by Wall St. Rank hold ELOX as of Q3 2020.

  • SG Americas Securities reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 363 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $44K.
  • SG Americas Securities first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • SG Americas Securities's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $44K in Q2 2020.
  • 37 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.